Krumsiek, Andreas, Kropf, Siegfried and Gardemann, Andreas. "Tumor necrosis factor-α G
(–308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C
(–1562)T promoter polymorphism and risk and extent of ischemic heart disease"
Clinical Chemical Laboratory Medicine, vol. 46, no. 2, 2008, pp. 292-295.
https://doi.org/10.1515/CCLM.2008.027
Krumsiek, A., Kropf, S. & Gardemann, A. (2008). Tumor necrosis factor-α G
(–308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C
(–1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Clinical Chemical Laboratory Medicine,
46(2), 292-295.
https://doi.org/10.1515/CCLM.2008.027
Krumsiek, A., Kropf, S. and Gardemann, A. (2008) Tumor necrosis factor-α G
(–308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C
(–1562)T promoter polymorphism and risk and extent of ischemic heart disease. Clinical Chemical Laboratory Medicine, Vol. 46 (Issue 2), pp. 292-295.
https://doi.org/10.1515/CCLM.2008.027
Krumsiek, Andreas, Kropf, Siegfried and Gardemann, Andreas. "Tumor necrosis factor-α G
(–308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C
(–1562)T promoter polymorphism and risk and extent of ischemic heart disease"
Clinical Chemical Laboratory Medicine 46, no. 2 (2008): 292-295.
https://doi.org/10.1515/CCLM.2008.027
Krumsiek A, Kropf S, Gardemann A. Tumor necrosis factor-α G
(–308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C
(–1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Clinical Chemical Laboratory Medicine. 2008;46(2): 292-295.
https://doi.org/10.1515/CCLM.2008.027
Copied to clipboard